NPRC/Institute
Federal Medical-Biological Agency of Russia, Moscow, Russia; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia; others
Summary of Study
Recombinant Nucleocapsid-Based Vaccine Convacell®
Year Published
2023
References
DOI: 10.3390/vaccines11040874
Contact Info
Sevastyan Rabdano: sevastyan@rabdano.ru
Keywords
SARS-CoV-2, nucleocapsid, vaccine, immune response, primates
Coronavirus Investigated*
NHP Species
date entered
Study Type